$244 Million is the total value of TRV GP III, LLC's 7 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PLRX | PLIANT THERAPEUTICS, INC. | $46,772,000 | +14.3% | 5,839,160 | 0.0% | 19.13% | +72.2% | |
| VYGR | VOYAGER THERAPEUTICS, INC. | $37,772,000 | -22.4% | 6,391,176 | 0.0% | 15.45% | +16.9% | |
| NRIX | NURIX THERAPEUTICS, INC. | $24,359,000 | -9.6% | 1,922,549 | 0.0% | 9.96% | +36.3% | |
| FULC | FULCRUM THERAPEUTICS, INC. | $19,415,000 | -79.3% | 3,962,202 | 0.0% | 7.94% | -68.8% | |
| DBTX | DECIBEL THERAPEUTICS, INC. | $13,218,000 | +38.5% | 3,139,685 | 0.0% | 5.41% | +108.7% | |
| JNCE | JOUNCE THERAPEUTICS, INC. | $3,481,000 | -55.4% | 1,148,780 | 0.0% | 1.42% | -32.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Mark Levin #1
- Kevin P. Starr #2
- Robert I. Tepper #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VOYAGER THERAPEUTICS, INC. | 22 | Q1 2023 | 74.0% |
| JOUNCE THERAPEUTICS, INC. | 20 | Q3 2022 | 24.5% |
| PLIANT THERAPEUTICS, INC. | 14 | Q3 2023 | 100.0% |
| FULCRUM THERAPEUTICS, INC. | 14 | Q4 2022 | 43.8% |
| REVOLUTION MEDICINES, INC. | 12 | Q4 2022 | 53.8% |
| DECIBEL THERAPEUTICS, INC. | 10 | Q2 2023 | 66.3% |
| NEON THERAPEUTICS, INC. | 8 | Q1 2020 | 41.1% |
| NURIX THERAPEUTICS, INC. | 8 | Q2 2022 | 17.7% |
| RELAY THERAPEUTICS, INC. | 2 | Q4 2020 | 37.7% |
| MYOKARDIA, INC. | 2 | Q1 2018 | 22.1% |
View TRV GP III, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 4 | 2023-02-06 |
| 4 | 2023-02-01 |
| 4 | 2023-01-31 |
| 4 | 2023-01-26 |
| 4 | 2023-01-24 |
View TRV GP III, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.